다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

CGEN

Compugen (CGEN)

Compugen Ltd

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CGEN

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/15	20:02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CGEN	Compugen Ltd
2024/05/15	20:00	PR Newswire (US)	Compugen Appoints David Silberman as Chief Financial Officer	NASDAQ:CGEN	Compugen Ltd
2024/05/06	20:00	PR Newswire (US)	Compugen to Release First Quarter 2024 Results on Monday, May 20, 2024	NASDAQ:CGEN	Compugen Ltd
2024/04/25	20:00	PR Newswire (US)	Compugen to Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024	NASDAQ:CGEN	Compugen Ltd
2024/04/10	20:00	PR Newswire (US)	Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503	NASDAQ:CGEN	Compugen Ltd
2024/04/03	20:00	PR Newswire (US)	Compugen to Participate in Two Upcoming Investor Conferences	NASDAQ:CGEN	Compugen Ltd
2024/03/11	20:00	PR Newswire (US)	Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy	NASDAQ:CGEN	Compugen Ltd
2024/03/06	21:00	PR Newswire (US)	Compugen to Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024	NASDAQ:CGEN	Compugen Ltd
2024/03/06	06:06	Edgar (US Regulatory)	Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]	NASDAQ:CGEN	Compugen Ltd
2024/03/05	21:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CGEN	Compugen Ltd
2024/03/05	21:00	PR Newswire (US)	Compugen Reports Fourth Quarter and Full Year 2023 Results	NASDAQ:CGEN	Compugen Ltd
2024/03/05	20:05	IH Market News	U.S. Futures Dip, Crude Oil Fluctuates	NASDAQ:CGEN	Compugen Ltd
2024/02/26	21:00	PR Newswire (US)	Compugen to Present at the Leerink Partners Global Biopharma Conference 2024	NASDAQ:CGEN	Compugen Ltd
2024/02/20	21:00	PR Newswire (US)	Compugen to Release Fourth Quarter and Full Year 2023 Results on Tuesday, March 5, 2024	NASDAQ:CGEN	Compugen Ltd
2024/02/15	21:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CGEN	Compugen Ltd
2024/02/15	21:00	PR Newswire (US)	Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer	NASDAQ:CGEN	Compugen Ltd
2024/01/08	21:10	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CGEN	Compugen Ltd
2024/01/08	21:05	PR Newswire (US)	Compugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer	NASDAQ:CGEN	Compugen Ltd
2024/01/08	21:00	PR Newswire (US)	Compugen Regains Compliance with Nasdaq Minimum Bid Price Requirement	NASDAQ:CGEN	Compugen Ltd
2023/12/19	23:30	AllPennyStocks.com	Strong Open For Biotech Following Exclusive Agreement Announcement	NASDAQ:CGEN	Compugen Ltd
2023/12/19	21:12	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CGEN	Compugen Ltd
2023/12/19	21:10	PR Newswire (US)	Compugen will be Eligible to Receive $10 Million Milestone Payment upon Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer	NASDAQ:CGEN	Compugen Ltd
2023/12/19	21:05	PR Newswire (US)	Compugen to Host Conference Call to Discuss Exclusive License Agreement with Gilead for COM503, Novel Immuno-Oncology Pre-Clinical Program Harnessing IL-18 Biology	NASDAQ:CGEN	Compugen Ltd
2023/12/19	21:00	Business Wire	Gilead and Compugen Announce Exclusive License Agreement for Novel Pre-Clinical Immunotherapy Program	NASDAQ:CGEN	Compugen Ltd
2023/11/07	21:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CGEN	Compugen Ltd
2023/11/07	21:00	PR Newswire (US)	Compugen Reports Third Quarter 2023 Results	NASDAQ:CGEN	Compugen Ltd
2023/11/06	21:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CGEN	Compugen Ltd
2023/11/06	21:00	PR Newswire (US)	Compugen's COM701 (anti-PVRIG) Mediates Anti-Tumor Activity in Patients Typically Not Responding to Immunotherapy	NASDAQ:CGEN	Compugen Ltd
2023/11/04	05:35	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CGEN	Compugen Ltd
2023/11/04	05:35	PR Newswire (US)	Compugen Announces Receipt of Nasdaq Minimum Bid Price Notification	NASDAQ:CGEN	Compugen Ltd

검색 관련기사 보기:NASDAQ:CGEN

1 2 3 4 5 6 7 8 9 10 다음 >>

American Express

Financial Select Sector

Deutsche Telekom (QX)

Energy Select Sector SPDR

Gold vs US Dollar

Health Care Select Sector

JP Morgan Chase

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관